FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365448889> ?p ?o ?g. }

• W4365448889 abstract "The efficacy of nanomedicines is dependent on their access to target sites in the body, and this in turn is affected by their size, shape and transport properties in tissue. Although there have been many studies, the ability to design nanomaterials with optimal physicochemical properties for in vivo efficacy remains a significant challenge. In particular, it is difficult to quantify the detailed effects of cancer drug delivery systems in vivo as tumour volume reduction, a commonly reported marker of efficacy, does not always correlate with cytotoxicity in tumour tissue. Here, we studied the behaviour in vivo of two specific poly(2-hydroxypropyl methacrylamide) (pHPMA) pro-drugs, with the same chemical compositions of redox-responsive backbone components and pH-sensitive linkers to the anti-cancer drug doxorubicin but with varying architectures, in this case hyperbranched and star-shaped. Evaluation of the biodistribution of these polymers following systemic injection indicated differences in the circulation time and organ distribution of the two polymers, despite their very similar hydrodynamic radii (~ 10 and 15 nm) and underlying chemistry of backbone, side-chain and pro-drug linkers. In addition, both polymers showed improved tumour accumulation in orthotopic triple-negative breast cancers in mice, and decreased accumulation in healthy tissue, as compared to free doxorubicin. Importantly, there was a significant increase in tumour accumulation for the hyper-branched polymer compared to the star polymer, suggesting a possible role for solution conformations of these materials, rather than the chemistries, in mediating their performance. The results of haematoxylin and eosin assays, and TUNEL staining indicated a higher population of apoptotic cells in the tumours for both polymer pro-drug treatments, and in turn a lower population of apoptotic cells in the heart, liver and spleen, as compared to free doxorubicin. In particular, the hyperbranched polymer demonstrated significantly higher tumour deposition and apoptosis levels than its star shaped counterpart. Taken together, these data suggest that the penetration of both of these polymer pro-drugs was enhanced in tumour tissue relative to free doxorubicin, and that the combination of size, architecture, bioresponsive backbone and drug linker degradation yielded greater efficacy for the polymers as measured by biomarkers other than that of tumour volume." @default.
• W4365448889 created "2023-04-15" @default.
• W4365448889 creator A5012990677 @default.
• W4365448889 creator A5019725924 @default.
• W4365448889 creator A5025427179 @default.
• W4365448889 creator A5027280548 @default.
• W4365448889 creator A5029836300 @default.
• W4365448889 creator A5033723598 @default.
• W4365448889 creator A5034302686 @default.
• W4365448889 creator A5059878597 @default.
• W4365448889 creator A5065540500 @default.
• W4365448889 creator A5081645339 @default.
• W4365448889 date "2023-04-13" @default.
• W4365448889 modified "2023-10-14" @default.
• W4365448889 title "Polymer Architecture Alters Tissue Distribution and Enhances Cytotoxicity Profiles in Orthotopic Models of Triple Negative Breast Cancers" @default.
• W4365448889 doi "https://doi.org/10.26434/chemrxiv-2023-8f0lk" @default.
• W4365448889 hasPublicationYear "2023" @default.
• W4365448889 type Work @default.
• W4365448889 citedByCount "0" @default.
• W4365448889 crossrefType "posted-content" @default.
• W4365448889 hasAuthorship W4365448889A5012990677 @default.
• W4365448889 hasAuthorship W4365448889A5019725924 @default.
• W4365448889 hasAuthorship W4365448889A5025427179 @default.
• W4365448889 hasAuthorship W4365448889A5027280548 @default.
• W4365448889 hasAuthorship W4365448889A5029836300 @default.
• W4365448889 hasAuthorship W4365448889A5033723598 @default.
• W4365448889 hasAuthorship W4365448889A5034302686 @default.
• W4365448889 hasAuthorship W4365448889A5059878597 @default.
• W4365448889 hasAuthorship W4365448889A5065540500 @default.
• W4365448889 hasAuthorship W4365448889A5081645339 @default.
• W4365448889 hasBestOaLocation W43654488891 @default.
• W4365448889 hasConcept C109316439 @default.
• W4365448889 hasConcept C110121322 @default.
• W4365448889 hasConcept C121608353 @default.
• W4365448889 hasConcept C12554922 @default.
• W4365448889 hasConcept C126322002 @default.
• W4365448889 hasConcept C134306372 @default.
• W4365448889 hasConcept C136229726 @default.
• W4365448889 hasConcept C142724271 @default.
• W4365448889 hasConcept C150903083 @default.
• W4365448889 hasConcept C15920480 @default.
• W4365448889 hasConcept C178790620 @default.
• W4365448889 hasConcept C185592680 @default.
• W4365448889 hasConcept C202751555 @default.
• W4365448889 hasConcept C207001950 @default.
• W4365448889 hasConcept C2775961978 @default.
• W4365448889 hasConcept C2776694085 @default.
• W4365448889 hasConcept C2776919888 @default.
• W4365448889 hasConcept C2777807558 @default.
• W4365448889 hasConcept C2779402116 @default.
• W4365448889 hasConcept C2779820397 @default.
• W4365448889 hasConcept C2780110267 @default.
• W4365448889 hasConcept C2781303535 @default.
• W4365448889 hasConcept C33923547 @default.
• W4365448889 hasConcept C502942594 @default.
• W4365448889 hasConcept C521977710 @default.
• W4365448889 hasConcept C530470458 @default.
• W4365448889 hasConcept C55493867 @default.
• W4365448889 hasConcept C71924100 @default.
• W4365448889 hasConcept C74864618 @default.
• W4365448889 hasConcept C86803240 @default.
• W4365448889 hasConceptScore W4365448889C109316439 @default.
• W4365448889 hasConceptScore W4365448889C110121322 @default.
• W4365448889 hasConceptScore W4365448889C121608353 @default.
• W4365448889 hasConceptScore W4365448889C12554922 @default.
• W4365448889 hasConceptScore W4365448889C126322002 @default.
• W4365448889 hasConceptScore W4365448889C134306372 @default.
• W4365448889 hasConceptScore W4365448889C136229726 @default.
• W4365448889 hasConceptScore W4365448889C142724271 @default.
• W4365448889 hasConceptScore W4365448889C150903083 @default.
• W4365448889 hasConceptScore W4365448889C15920480 @default.
• W4365448889 hasConceptScore W4365448889C178790620 @default.
• W4365448889 hasConceptScore W4365448889C185592680 @default.
• W4365448889 hasConceptScore W4365448889C202751555 @default.
• W4365448889 hasConceptScore W4365448889C207001950 @default.
• W4365448889 hasConceptScore W4365448889C2775961978 @default.
• W4365448889 hasConceptScore W4365448889C2776694085 @default.
• W4365448889 hasConceptScore W4365448889C2776919888 @default.
• W4365448889 hasConceptScore W4365448889C2777807558 @default.
• W4365448889 hasConceptScore W4365448889C2779402116 @default.
• W4365448889 hasConceptScore W4365448889C2779820397 @default.
• W4365448889 hasConceptScore W4365448889C2780110267 @default.
• W4365448889 hasConceptScore W4365448889C2781303535 @default.
• W4365448889 hasConceptScore W4365448889C33923547 @default.
• W4365448889 hasConceptScore W4365448889C502942594 @default.
• W4365448889 hasConceptScore W4365448889C521977710 @default.
• W4365448889 hasConceptScore W4365448889C530470458 @default.
• W4365448889 hasConceptScore W4365448889C55493867 @default.
• W4365448889 hasConceptScore W4365448889C71924100 @default.
• W4365448889 hasConceptScore W4365448889C74864618 @default.
• W4365448889 hasConceptScore W4365448889C86803240 @default.
• W4365448889 hasLocation W43654488891 @default.
• W4365448889 hasOpenAccess W4365448889 @default.
• W4365448889 hasPrimaryLocation W43654488891 @default.
• W4365448889 hasRelatedWork W1969303838 @default.
• W4365448889 hasRelatedWork W1984850590 @default.
• W4365448889 hasRelatedWork W1985237528 @default.
• W4365448889 hasRelatedWork W2005862238 @default.
• W4365448889 hasRelatedWork W2042583456 @default.
• W4365448889 hasRelatedWork W2613414080 @default.

• next